FEAT DAILY NEWSLETTER
Sacramento, California http://www.feat.org
February 12, 2002
News Morgue Search www.feat.org/search/news.asp
·
Autistic Child Found at Pompano Beach, Florida
·
What Wakefield is Doing Is Unforgivable
·
MMR Contains Same Strains of Virus As In The Single
Vaccines
·
New Research on Autism And Measles “Proves Nothing”
·
What it DOES Prove
·
Repligen Does the Research
·
NYTimes: Britain Tries to Quell Fear Over Vaccine for
Children
·
Wash. Post: New Measles Cases in Britain Add to Concern
Over Vaccine
·
S. Florida Sun-Sentinel: Is There A Link Between
Vaccines And Autism?
·
Reader’s Posts
[This report is combined from articles from WPLG and
the Miami
Herald.]
http://dailynews.yahoo.com/h/wplg/20020211/lo/1073947_1.html
and http://www.miami.com/mld/miami/news/local/2646219.htm
Dive teams have found the body of a five-year old autistic
boy in Pompano Beach, Florida missing since Sunday morning.
The boy’s body was in a canal near his home just
before 9:00 a.m.
Monday morning.
The last time family members said they saw 5-year-old Jordan
Payne, he was sleeping under a quilt during a weekend trip to his dad’s house.
Sunday, Broward Sheriff’s Office deputies and
investigators in Pompano Beach spent the day searching for the autistic boy who
cannot speak and needs to take medication to keep him from having seizures.
His great-grandmother, Willa Richardson, 73, said she
checked on him around 11 p.m. Saturday and he was asleep.
Jordan’s dad, Tommie Payne, who lives with Richardson,
said the boy wasn’t there Sunday morning when he went to wake him.
The search stretched at least six square miles. Six search
dogs roamed the area, divers probed a nearby waterway and a helicopter flew
over the Canal Pointe neighborhood in Pompano Beach. Automated telephone calls
went out alerting neighbors that a child had disappeared. Deputies passed out fliers
door-to-door and in the street. Police continued to search through the night.
Jordan, who would have been six next month, sometimes
wandered out the front door, his parents said. But he didn’t usually go far.
Jordan’s mother, Zola Hayes, is separated from Payne. She
dropped the boy off Saturday to spend the night with his dad and other family
members at the home in the 1500 block of Northwest Seventh Terrace.
Family members told police Jordan went to bed around 9
p.m. Saturday and that his great-grandmother checked on him and his three
cousins around 11.
Payne woke up around 8 a.m. Sunday and went to wake Jordan
to give him his medicine and breakfast.
He wasn’t in bed. A search of the house, regular hiding
places and neighborhood didn’t turn him up either. The family notified police
shortly before 10 a.m.
* * *
What Wakefield is Doing Is Unforgivable
MMR Row Putting Young Lives At Risk.
[By Bill Greig in the Express on Sunday, UK. There is
a perjorative
characterization made of an autism mother. The Express is
considered a
tabloid, crude British newspaper, which makes it indistinct
in the opinion
of some American news trackers. -LS.]
The row over the MMR vaccine is one of the most
disgraceful I can remember in my many years of writing about British politics.
Stand condemned Dr Wakefield, whose stubborn one-man
campaign will probably lead to the deaths or handicapping of dozens of children
and will not stop one child from becoming autistic.
Meanwhile, many parents are charging lemming-like towards
a return to the dark ages, preferring to believe the myths of the scaremongers
rather than the scientists who, no doubt, are going to be the next target for
the antieverything anarchists.
Why am I so certain that Wakefield is wrong? Because I
have just spent a week tracking down studies from around the world, which all
come to the conclusion that there no link between the vaccine and autism.
And the important point about Wakefield’s own studies is
that he has been unable to prove a link either. Even when his original study -
carried out on only 12 patients - was published in The Lancet, that publication
carried an editorial which effectively dismissed his claims.
But, of course, parents are bound to be deeply concerned
about something which they think could harm their children so all it requires
is Wakefield and a few fellow travellers to sow doubt and the result is near panic.
What Wakefield is doing is unforgivable. In the absence of
scientific proof, he keeps pushing a theory which none of his peers believe has
any scientific basis.
Last week on radio, I heard an idiot of a woman make the
claim that the circumstantial evidence for a link between the vaccine and
autism was overwhelming.
That is a lie. There is a small group of parents who
believe that their children only became autistic after receiving the MMR
vaccination. They are entitled to make
that claim - to watch a healthy child become autistic must be utterly awful.
Autism is definitely increasing in America, say the
MMR critics.
This is usually based on a raw Californian census
which appears to
show a 300 per cent increase in the number of autistic
children.
But the figures were not balanced. They did not take into
account a 25 per cent increase in the population over the same period, or
population movement or a simple fact that it was known parents of autistic
children were, in fact, moving from adjoining states to receive treatment for
them in Californian centres.
More importantly, even if the Californian figures were correct
and MMR was to blame, the increase in vaccinations should have paralleled the increase
in autism, but immunisation had only gone up by 14 per cent.
Of course, argue the critics, looking for another
conspiracy theory, the drug companies and doctors are closely linked. Even if
this was the case, the problem is that the drug companies would make more money
from single vaccines than the three-in-one MMR so if they are backing the
latter they are not doing it to boost their profits.
Just as dangerous as the anti brigade are those like Tory
health spokesman Dr Liam Fox, who argue that because parents are concerned, the
Government should make the single vaccine available.
The antis would immediately claim that this was proof the
Government had doubts too.
This should be a non-political issue. All the parties
should unite and back proven science against backwoods mumbo-jumbo. If not,
then children’s lives will be lost.
>>> PROFESSORS, TEACHERS, TRAINERS
<<<
Autism Continuing Education for
Students Now Available
FEAT Daily Newsletter, NO FEE
For the Knowledge Only, No CEUs
* * *
MMR Contains Same Strains of Virus As In The Single
Vaccines
http://www.thetimes.co.uk/article/0,,7-204458,00.html
In cold scientific terms, the Government has a compelling
case for saying that the MMR jab is safe. It was introduced in Britain in 1988
and is used in at least 30 countries, including the US and Canada. Five hundred
million doses have been administered worldwide and countries that support it have
seen the three diseases almost eradicated.
The South London outbreak, where vaccination levels have
fallen to 73 per cent (the World Health Organisation says a level of 95 per
cent is required to prevent epidemics) shows that vaccination succeeds in
keeping the diseases at bay. But there are thought to be 1,000 families who
believe that the vaccine has damaged their children.
The MMR jab in Britain and America is manufactured as MMR
II by the pharmaceutical giant Merck. It comprises three live attenuated
viruses. “Attenuated” means the vaccine
contains small portions of viruses of measles (Edmonston strain), mumps (Jeryl
Lynn) and rubella (RA27/3). The dangerous segments of the viruses have been
removed, leaving enough biological material to tutor a child’s immune system to
recognise the whole virus but not enough to cause disease. When a child
encounters one of them, the immune system, primed by the jab, can recognise it
and produce antibodies to kill it. The vaccine is administered in two stages:
an injection at age 12 to 15 months and a booster before a child joins school.
The vaccine is not advised for those with “impaired
immunity” or a history of allergy to vaccines or egg. Listed adverse reactions
for those who have the vaccine include malaise, rash, fever and nausea. Those,
say doctors, are nothing compared with the consequences of, say, measles, which
causes the deadly brain disease encephalitis in one in 1,000 children.
What about the main voice behind concerns, Dr Andrew
Wakefield, a consultant gastroenterologist? He left the Royal Free Hospital in
North London by mutual agreement last year, and is now at the International
Child Development Resource Centre in Florida. He published a paper in The
Lancet in 1988, looking at 12 patients with bowel disorders. Nine were later diagnosed
with autism; all but one had been given the MMR jab (one had caught measles).
Wakefield contends that the MMR triggers a bowel disease in some children:
toxins can leak from the gut into the bloodstream, which subsequently impedes brain
development. Hence his call for single vaccines to be available.
But Wakefield’s research papers show no clear link. For
example, a research paper to appear in the April issue of the journal Molecular
Pathology shows that among 91 children with developmental disorders and bowel
disease, 75 had the measles virus in intestinal (gut) tissue. Of 70 healthy
children, only five had the measles virus in their gut. Wakefield supplied the
tissue and is listed as a co-author.
Yet the researchers did not look to see which of the
children had been given MMR (Wakefield said later that most children had been
given it but several had had the single measles vaccine, which implies that
single vaccines may be just as risky for vulnerable children.) Neither did they
seek to establish whether the measles strain found in the gut tissue of affected
children matched those in the vaccine, which would be a vital piece of
scientific evidence.
Professor John O’Leary, a molecular pathologist in Dublin
who co-authored the paper, said: “I stand by the findings of our research,
which raises many questions about whether measles virus has a role in bowel inflammation
in developmental disorder. But the research did not set out to investigate the
role of MMR in the development of either bowel disease or developmental
disorder, and no conclusions about such a role could, or should be, drawn from
our findings.”
The editors of the journal added: “The paper did not set
out to investigate the role of MMR in developmental disorders or bowel disease,
and no role for MMR is suggested in it.”
* * *
[By Lynn Eaton, BMJ.]
http://bmj.com/cgi/content/full/324/7333/315/a?view=full&pmid=11834548
Controversial new research showing that many children with
both autism and bowel disease have the measles virus in their intestinal tissue
has fuelled further debate over the possible link between the illness and the measles,
mumps, and rubella vaccine <<...>> although no such link is proved in
the research.
The paper, to be published shortly by the specialist
journal Molecular Pathology (which is co-owned by the BMJ Publishing Group) and
already available on its website (<http://mp.bmjjournals.com/cgi/content/full/54/6/DC1>),
was highlighted by a television programme (Panorama, BBC1, 3 Feb) on the safety
of the MMR vaccine.
It looked at tissue samples of 91 children from the Royal
Free Hospital, London, who had both autism and inflammatory bowel disease. Seventy five of the samples tested positive
for the presence of measles virus in intestinal tissue, compared with five of
70 controls.
Professor John O’Leary, of the department of pathology at
Coombe Women’s Hospital, Dublin, who undertook the analysis, emphasised that
the results did not prove that any of the children acquired their condition as
a result of being vaccinated.
“You can’t say at the moment that it is linked to the
vaccine,” he said. “There are several strains of the virus out there. They
could have picked it up from the wild virus.”
But he thought it unlikely that parents would have missed measles
symptoms in their child. “A measles rash is pretty classic,” he said. “The
child is irritable and gets a fever. The parents would probably have spotted
that.” He said the paper had been very carefully
prepared, because this was such a major public health issue. “It is fair to say
these children are not representative of autism per se,” he said. “It is a very
distinctive subset. The important point we are trying to get across is that it
is a biological association.”
Alan Morris, reader in the department of biological
sciences, Warwick University, and author of the journal’s commentary on the
paper, described it as “interesting.” “The
paper is technically good. The data look fine, but it is looking at an unusual
subset of children and it proves nothing.
Its implications will only come out in the wash.” But one of the paper’s authors, Dr Andrew
Wakefield, a former senior lecturer at the Royal Free Hospital and the main
advocate for a link between the MMR vaccine and autism (Lancet
1998;351:637-41[Medline]
</cgi/external_ref?access_num=9500320&link_type=MED>),
said the study raised important questions.
“We don’t know whether it is the vaccine strain or not,”
he admitted, “but these children’s only exposure has been to the vaccine
strain. None of them had a history of measles. It takes the science to an
entirely new level.”
Dr Wakefield worked at the Royal Free Hospital, where the
samples came from, until last November, when he was told that his research was “no
longer in line with the department of medicine’s research strategy.”
* * *
http://bmj.com/cgi/eletters/324/7333/315/a#19463
The response I have read proves one thing. The status quo
is being defended “at all odds” while kids continue to be adversely affected by
something which no-one is prepared to look into seriously. Most of the responses
to Wakefield’s work and his potentially alarming findings has been a rather
shameful reactive and data-fudging repetitive reassertion of “It is all OK “
when it clearly is not.
While it is equally clear that the majority do not get
adversely affected, until we know what it is about the subgroup who do report time-associated
reactions, it surely behoves the companies who make these vaccines or the
governments who advocate them in such a fear-engendering way, to respond with
research designed to find out why. Otherwise the charge that all is directed to
protecting drug company profit will hang around.
My reading suggests that those with a family history of
G-protein related diseases are more likely to react. Many of the patients I
have, who complain of fundamental changes in their childrens character or of
the onset of a condition classifiable as part of the autistic spectrum also
report night blindess in one of the parents. This issue has already been
addressed by Dr Mary Megson, but the association and its implications remains unaddressed
by the research community unless I am mistaken.
STATISTICS RELATING TO VACCINE SAFETY MEAN ABSOLUTLEY
NOTHING when your
child is affected FOR LIFE. Until such independant
rigourous and exhaustive research has been conducted into this issue along with
other vaccine associated concerns I remain supportive of parents rights to
decide whether or not to vaccinate their children.
Philip Stowell,
Brisbane, Australia.
GP and father of two boys
>> DO SOMETHING ABOUT AUTISM NOW <<
Subscribe, Read, then Forward the FEAT Daily
Newsletter.
To Subscribe go to www.feat.org/FEATnews
No Cost!
* * *
American Press Starting to Cover MMR - Vaccine UK
Controversy
NYTimes: Britain Tries to Quell Fear Over Vaccine for
Children
[By Sarah Lyall.]
The British government is struggling to quell fears about
a common childhood vaccine that increasing numbers of parents believe may be
linked to autism, despite strong official assurances to the contrary.
At issue is the so-called MMR vaccine, which immunizes
children against
measles, mumps and rubella, three potentially deadly
diseases that were once
common and have been mostly wiped out. The government says
that the vaccine,
which is administered in two doses, the first when babies
are about 18
months old, is perfectly safe.
http://www.nytimes.com/2002/02/10/international/europe/10VACC.html
* * *
Wash. Post: New Measles Cases in Britain Add to Concern
Over Vaccine
Inoculation Rate Declines as Study Stirs Parents’ Fears
[By T.R. Reid. Friday, February 8, 2002]
Public health officials reported a dozen new cases of
measles this week as Britain’s latest health scare—this time focusing on a
vaccine used in 90 countries around the world—prompted thousands of parents to refuse
to allow their children to receive the recommended shot of measles, mumps, and
rubella vaccine.
Britain’s chief medical officer, Sir Liam Donaldson,
warned today that the country faced a resurgence of the three childhood
diseases, and Prime Minister Tony Blair accused the media of “totally
irresponsible scaremongering” about the vaccine.
But parents continued to express doubt, and the
vaccination rate in
some cities was falling sharply, the National Health Service
said. Some
Britons are having their children vaccinated separately for
each of the
diseases, a method they believe is safer but that the
government calls less
effective.
http://www.washingtonpost.com/wp-dyn/articles/A42102-2002Feb7.html
* * *
[Liz Doup.]
A few weeks after Steven Demos turned 1, his mother
noticed a difference. He stopped looking her in the eye. He started flapping
his arms. Around 18 months,
high-pitched screams replaced his words.
When Steven was 3, a neurologist diagnosed autism, a
neurological disorder that severely affects a child’s ability to communicate
and learn.
Now Steven is the subject of a lawsuit against the nation’s
major vaccine manufacturers. His parents, Linda and Nick Demos of North Miami Beach,
believe his autism is linked to vaccinations containing mercury.
The Demos family is hardly alone. A coalition of 35
law firms, headed
by a Portland, Ore., attorney, is currently handling
lawsuits for about
1,000 families nationwide.
http://www.sun-sentinel.com/features/sfl-livaccinefeb10.story
* * *
[A note on yesterday’s article on Secretin, “Secretin
Takes Another Research Hit.” One reader
writes in to note that the study does not take into account its effectiveness
with subgroups and therefore is not really “a hit.”
Another reader writes in to add that Repligen is doing
much to advance our understanding of autism and develop methods for assessing
its efficacy in this difficult to measure population. The following are excerpts from press releases made by Repligen
just last week. –LS]
Repligen Announces Conference Call to Update Autism Phase
3 Clinical Program www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/02-08-2002/0
001665520&EDATE <- - address ends here.
Repligen Corporation announced Feb. 8 that the Company President
and Chief Executive Officer, Walter C. Herlihy, Ph.D., will host a conference call
and webcast on Friday, February 15, at 11 a.m. EST, to update the company’s
Phase 3 clinical program in autism. The company is evaluating the ability of
secretin to improve reciprocal social interaction, a core symptom of autism, in
young children with the disorder. Dr. Herlihy will be joined by Helen
Tager-Flusberg, Ph.D., the primary psychometric consultant for the trial.
Dr. Tager-Flusberg has been asked to join the call to
provide an expert perspective on the tools for diagnosis and assessment of the
symptoms of autism. Dr. Tager-Flusberg is the Director of the Laboratory on Developmental
Cognitive Neurosciences at Boston University School of Medicine and is a
Principal Investigator of an NIH-funded Collaborative Program of Excellence in
Autism.
Please access the call at 10:55 a.m. EST on Friday,
February 15th via the internet at http://www.vcall.com/EventPage.asp?ID=80734
or via the Repligen web site at www.repligen.com. To listen to the webcast
via the internet, please go to the web site at least five minutes early to
register, and if necessary install Real Player audio software. If you are
unable to access the webcast via the internet, you may also listen to the live broadcast
by calling 1 - 888 - 280 - 8771. For those who cannot participate in the live
conference call, an archive will be available shortly after the call at http://www.vcall.com/EventPage.asp?ID=80734
for 90 days.
* *
www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/02-07-2002/0
001664666&EDATE <- - address ends here.
During the quarter we submitted a Phase 3 clinical trial
plan to the Food and Drug Administration (FDA) to evaluate the ability of
secretin to improve reciprocal social interaction, a core symptom of autism, in
young children with the disorder. The Phase 3 trials are expected to begin in
the first quarter of calendar year 2002 and will seek to enroll 300 children with
autism who will receive six doses of secretin or a placebo, once every three
weeks.
We have completed five multi-dose animal safety and
toxicology studies and submitted the results of these studies to the FDA. Based
on the program’s designation as Fast Track, we have been advised by the FDA
that there are no additional animal safety and toxicology studies required at this
time to support the submission of a New Drug Application, provided the safety
profile of secretin in the Phase 3 study is consistent with the results
observed in the Phase 2 study. If a New Drug Application is approved for
secretin treatment of autism, further animal studies may be required post NDA
approval.
* *
Repligen and McLean Hospital Initiate Brain Imaging Study of
Secretin
Clinical Study to Assess Activation of Amygdala by Secretin
in Healthy
Adults
www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/02-06-2002/0
001663903&EDATE <- - address ends here.
Repligen Corporation announced today the initiation of a
clinical trial to assess the neurological activity of secretin by functional
Magnetic Resonance Imaging (fMRI). The study is being conducted in
collaboration with the Brain Imaging Center at McLean Hospital, a teaching
affiliate of Harvard Medical School.
The trial will assess the impact of a single injection of
secretin or a placebo on the activity of the amygdala, a social integration
center in the brain, in 12 healthy adults. Subjects will also perform facial recognition
tasks to determine if a single injection of secretin affects this aspect of
social awareness. This study is part of a comprehensive clinical program to
evaluate secretin for the improvement of social interaction in children with
autism.
* * *
I am an autism therapist working
with a two and a half year old boy who is having tremendous trouble sleeping. I’m
trying to find as much information on how to help this little boy and his
parents deal with it. Any information is greatly appreciated. You can email me at beccasuehi@aol.com.
Seeking psychologist (Ph.D.,
Ed.D., or Psy.D.) licensed (or eligible) in Pennsylvania to be part of the
launch of the Autism Spectrum Resource Center in Philadelphia suburbs.
Experience and/or interest in autistic spectrum disorders required. Full-time
practitioner to build solo practice with the support and resources of a
multi-disciplinary team. Send C.V. and background to mrcohen1@erols.com.
Need to find a vision therapy specialist in the San Jose
area that works
with children who have Autism. A parent from Guam will be in
the San Jose
area in March with her 6 year old son who has Autism. She
sent me an email
asking If I knew of a specialist. I don’t, and have looked
and have had no
success. If you can help I would greatly appreciate it. Barbie Dunham
California Co. State Rep. for
Unlocking Autism, CTLAUTISM@aol.com
Notice of Correction: In a
company announcement that appear last week in the FEAT Daily Newsletter,
Emergency Notification Systems provided a link to a website that mistakenly
refered to Dennis Debbaudt as a police officer. The error has been corrected.
Emergency Notification Systems regrets any confusion this may have caused.
>>
FREE (Almost) READER’S POSTS <<
For Individuals, organizations, non-commercial and commercial.
Limit your posting to no more than 60 words please. There is no charge for this
service, but posters are obligated to thank all those who take the time to
answer your ads. This is a consideration for others with autism after you and
yours, who seek assistance from appreciated readers. Send submissions to:
Lenny Schafer, Editor@feat.org • CALENDAR EVENTS@feat.org
Michelle Guppy
Catherine Johnson PhD
• Ron Sleith •
Kay Stammers • Edward Decelie
UNSUBSCRIBE: FEATNews-signoff-request@LIST.FEAT.ORG
ALL
INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR
GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE
KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED
AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO
VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU
ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.